Summary
Adil Mardinoglu is a Professor of Systems Biology and group leader split between King’s College London and KTH/Scilifelab, leading a multidisciplinary team of 25 researchers to translate computational and experimental networks into new therapies for metabolic, neurodegenerative and certain cancers. He specializes in context-specific genome-scale metabolic models for human tissues and tumors and integrates metabolic models with regulatory, signalling and protein–protein networks to uncover disease mechanisms, biomarkers and drug targets. With a background in electronic engineering and a PhD from Waterford Institute of Technology, he blends engineering rigor with systems biology to develop reproducible, network-driven strategies for drug development. Based in Stockholm and active in academia for nearly a decade at senior levels, he is known for scaling model-driven insights from tissue-specific metabolism to actionable therapeutic hypotheses.
8 years of coding experience
4 years of employment as a software developer
Engineering, Electronic and Telecommunication Engineering, Engineering, Electronic and Telecommunication Engineering at Istanbul Technical University
PhD, PhD in Engineering, PhD, PhD in Engineering at Waterford Institute of Technology
Denizli Fen Lisesi